BioSpace News Archive

Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced five posters will be presented at the International Parkinson and Movement Disorder Society (MDS) Virtual Congress, taking place September 17 – 22, 2021.

Force Therapeutics, the leading patient engagement platform and research network, exceeded 110 clinical research publications today.

Asymchem (stock code: 002821.SZ) today announced a strategic partnership agreement to provide LaNova Medicines with one-stop services such as small molecule drugs, ADC project CMCs, R&D, production and IND China-US declaration.

The conference will be held virtually on September 20-23, 2021.

The 46th edition of the TIFF features 10 days of exceptional international and Canadian cinema with close to 200 films in its Official Selection, unparalleled events featuring acclaimed industry guests, and TIFF’s Industry Conference.

Launches Nordics Regional Expansion Dr. Lowan Stewart, One of Europe’s Preeminent Ketamine Physicians, Appointed as Awakn’s Regional Director for the Nordics.

The Massive Analysis and Quality Control (MAQC) Society, an organization seeking to promote and advance reproducible science principles and quality control, today announced the publication of a collection of journal articles in the September issue of Nature Biotechnology (NBT).

Exegenesis Bio is pleased to announce the appointment of Mahen Gundecha as Chief Business Officer.

GreenLight Biosciences, Inc. announced the appointment of Jennifer Raymond as SVP, CMC Manufacturing today.

Tabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, today announced the results of a three-part clinical study that further demonstrates the strong associations between a high MedWise Risk Score™ and poor health outcomes.